On 20 September 2007 the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending granting a marketing authorisation for the medicinal product Pioglitazone / ...
August 15, 2007 (Rockville, MD) - At the FDA's behest, GlaxoSmithKline and Takeda will be adding black-box warnings to their thiazolidinedione drugs for type 2 diabetes-- rosiglitazone (Avandia) and ...
Silver Spring, MD - The US Food and Drug Administration (FDA) today approved the first generic version of pioglitazone hydrochloride (Actos, Takeda Pharmaceuticals), which is used to improve blood ...
PRINCETON, N.J., Aug. 17, 2012 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc., a wholly owned subsidiary of Ranbaxy Laboratories Ltd. (RLL), has launched authorized generic pioglitazone hydrochloride ...
Reason for posting: Health Canada issued an advisory on Nov. 30, 2001,1 after receiving an increasing number of reports of congestive heart failure (CHF), pulmonary edema and pleural effusion ...
Reason for posting: Pioglitazone is an oral hypoglycemic agent widely used as monotherapy or combination therapy for type 2 diabetes mellitus. However, a recent analysis by the drug's manufacturer of ...
PITTSBURGH, Aug. 17, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (FDA ...
A diabetes drug can increase a person's risk of bladder cancer, researchers have found. The anti-diabetic drug pioglitazone helps to control blood sugar levels in patients with type 2 diabetes. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback